|
Volumn 384, Issue 9955, 2014, Pages 1667-
|
Randomisation is essential in Ebola drug trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
DRUG SCREENING;
EBOLA HEMORRHAGIC FEVER;
HUMAN;
INFORMED CONSENT;
LETTER;
MORTALITY;
PRIORITY JOURNAL;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ETHICS;
HEMORRHAGIC FEVER, EBOLA;
ANTIVIRAL AGENTS;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
EID: 84920869557
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(14)61735-9 Document Type: Letter |
Times cited : (11)
|
References (3)
|